What is more, higher CDCA2 expression was correlated to patients' survival in some cancer types, such as in lung adenocarcinoma (LAUD), Kidney renal papillary carcinoma (KIRP), and (liver hepatocellular carcinoma) LIHC (Supplemental Figure 1). This evidence concerns the gene CDCA2 and lung adenocarcinoma.